Researchers conducted a multicenter, double-blind, parallel-group, placebo-controlled, 1:1 randomized efficacy trial to assess the value of creatine monohydrate in patients with Parkinson's - Read more at http://ift.tt/171SvA3

Researchers conducted a multicenter, double-blind, parallel-group, placebo-controlled, 1:1 randomized efficacy trial to assess the value of creatine monohydrate in patients with Parkinson's - Read more at http://ift.tt/171SvA3